Cure For Pancreatic Cancer Can Come From mRNA Vaccines – This And More News In Digital Health This Week
Bertalan Meskó, MD, PhD
Director of The Medical Futurist Institute (Keynote Speaker, Researcher, Author & Futurist)
Last week was packed with thrilling breakthrough reports from the promise of an mRNA vaccine against pancreatic cancer, through the heart repairing gel and the 3D printed multilayer heart tissue to nanotechnology destroying solid tumours.
If you are also interested why nutrigenomics is still not producing accessible, consumer-grade tests , we listed four reasons. And also summarized how much our life is worth – if we look at ourselves as carriers of valuable organs, all coming with a price tag.
?"A new vaccine using the same mRNA technology as the Pfizer jab against COVID-19 could be a breakthrough in the fight against pancreatic cancer.
In a promising early study conducted by German company BioNTech — which partnered with Pfizer to develop the lifesaving COVID shot — half of the patients remained cancer-free 18 months after having their tumors removed and receiving the jabs."
What is nutrigenomics in simple terms? A promise of an advancement that can provide you with scientifically backed data on what, how and when you should eat and what to avoid – based on your DNA.
I’ll give you four reasons in my newest article to explain why it is the biggest flop in digital health.
The industry is changing with the speed of light, and the largest tech companies put significant effort (and billions of dollars) to make sure they will have a share in the future of this lucrative sector.
We have been analysing their progress for a long time now. These past two years were not short of big failures (let’s just think of the IBM Watson fiasco) and success stories (like Google/Alphabet and A.I), so it was time for a major update.
Multivitamins, drugs, gene therapies, human skin, heart, eyeballs, kidneys, entire dead bodies – everything comes with a price tag. Putting aside the moral questions of why and how come the capitalist market priced even our body parts and health, we asked the question of how much life is worth: what is the maximum that you would/should pay for a life-saving drug?
One of our “fan favorite” articles now comes in a revised and updated version to answer uncomfortable questions about the price of life.
领英推荐
Apple just announced new, medical features in its software updates. The Medications feature allows users to manage their medications. They can use the camera to scan a pill bottle to import information, set up schedules and receive alerts to take their medicines on time.
US users can also receive alerts about possible drug interactions. A new atrial fibrillation history feature with the upcoming watchOS 9. More tools for sleep tracking, and new workout features.
"This new system aims to mimic common scenarios for trainee nurses and doctors and allows them to make mistakes without causing any harm and without creating a risk.
The system is quite sophisticated and mimics common distractors found on busy healthcare wards to make the experience as realistic as possible."
Researchers from Harvard University’s Wyss Institute (one of the flagship centers for 3D bioprinting) have developed a suite of new heart engineering technologies that have enabled them to mimic the alignment of a human heart’s contractile elements.
"In the future, the team’s advance could enable the development of thick multi-layered human muscle tissue with more physiological contractile properties and, potentially, pave the way toward 3D printed heart tissue replacements."
MORE NEWS ABOUT THE FUTURE OF MEDICINE
SLIGHTLY SWEATY? – Scientists make ‘slightly sweaty’ robot finger with living skin
DIAPER ISSUES –? Inside the quest to redesign the diaper
Cambiando el mundo una persona a la vez - Universal Healthcare
2 年Study Type??:Interventional?(Clinical Trial) Actual?Enrollment??:29 participants Allocation:N/A Intervention Model:Single Group Assignment Masking:None (Open Label) Primary Purpose:Treatment Official Title:Phase 1 Clinical Trial of Personalized Neoantigen Tumor Vaccines and Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Surgically Resected Pancreatic Cancer Actual?Study Start Date??:November 11, 2019 Estimated?Primary Completion Date??:November 11, 2023 Estimated?Study Completion Date??:November 11, 2023
Founder at Chemical Industry ? Blockchain Enthusiast
2 年Vahid Khoddami